The study demonstrates that two defective genes within the AMG pathway can synergistically raise seizure risk, supporting a digenic framework that could improve genetic testing and reveal new therapeutic targets for drug-resistant or undiagnosed epilepsy cases.

A new study from Baylor College of Medicine and Texas Children’s Hospital identifies an actin–mitochondria–glutamate pathway as a genetic route to epilepsy, suggesting seizures can arise from combinations of defective genes rather than single targets.

Researchers focus on actin biology and cytoskeleton remodeling, expanding beyond traditional synaptic signaling to explain how genetic variants contribute to epilepsy.

The findings imply that many patients with epilepsy of unknown origin may carry combinations of defective AMG genes, and modeling these combinations supports the idea that interacting gene variants can raise seizure risk, offering new avenues for diagnosis and treatment development.

The proposed AMG pathway (actin–mitochondria–glutamate) links excess reactive oxygen species to enhanced glutamatergic transmission, creating an environment conducive to seizures.

Mutant actin leads to more mitochondria that are hyperactive, producing higher levels of reactive oxygen species, which in turn increases glutamatergic transmission and seizure propensity, defining an actin–mitochondria–glutamate (AMG) pathway.

Overall, the findings highlight a complex, pathway-based genetic basis for epilepsy and open avenues for targeted interventions beyond traditional synaptic-focused approaches.

Neuronal changes included altered mitochondria (more numerous, smaller) and signs of oxidative stress, without obvious changes in neuronal wiring, pointing to a functional mitochondrial involvement in seizure susceptibility.

Interventions in the AMG pathway reduced seizures in flies: the mitochondrial fragmentation blocker Mdivi-1 and an antioxidant/ROS reducer (NACA) both lowered seizure activity and aberrant glutamatergic signaling.

Inhibiting parts of the AMG pathway reduced seizures in fruit flies, and preventing mitochondrial fragmentation also suppressed seizures in sif mutants, indicating potential therapeutic targets within this pathway.

Researchers focused on actin-related genes and used fruit flies to model human epilepsy, examining the gene sif, a parallel to human TIAM1, finding that sif mutations cause seizures through defects in actin filaments and heightened neuronal activity without large structural neuronal changes.

Using fruit fly models with TIAM1-equivalent disruption (sif), the team observed seizures and disrupted actin filaments, with glutamatergic neurons being most affected, indicating a pathway-specific effect on seizure-driving circuits.